POPULARITY
Categories
325 episodes with pharmd
158 episodes with pharmd
151 episodes with pharmd
165 episodes with pharmd
144 episodes with pharmd
168 episodes with pharmd
178 episodes with pharmd
126 episodes with pharmd
111 episodes with pharmd
73 episodes with pharmd
104 episodes with pharmd
93 episodes with pharmd
83 episodes with pharmd
93 episodes with pharmd
114 episodes with pharmd
55 episodes with pharmd
44 episodes with pharmd
47 episodes with pharmd
32 episodes with pharmd
40 episodes with pharmd
47 episodes with pharmd
31 episodes with pharmd
37 episodes with pharmd
34 episodes with pharmd
53 episodes with pharmd
67 episodes with pharmd
22 episodes with pharmd
27 episodes with pharmd
27 episodes with pharmd
19 episodes with pharmd
31 episodes with pharmd
21 episodes with pharmd
15 episodes with pharmd
27 episodes with pharmd
24 episodes with pharmd
49 episodes with pharmd
16 episodes with pharmd
19 episodes with pharmd
16 episodes with pharmd
18 episodes with pharmd
22 episodes with pharmd
33 episodes with pharmd
11 episodes with pharmd
40 episodes with pharmd
32 episodes with pharmd
18 episodes with pharmd
17 episodes with pharmd
13 episodes with pharmd
18 episodes with pharmd
14 episodes with pharmd
53 episodes with pharmd
14 episodes with pharmd
15 episodes with pharmd
12 episodes with pharmd
12 episodes with pharmd
18 episodes with pharmd
18 episodes with pharmd
16 episodes with pharmd
13 episodes with pharmd
16 episodes with pharmd
14 episodes with pharmd
9 episodes with pharmd
40 episodes with pharmd
20 episodes with pharmd
15 episodes with pharmd
8 episodes with pharmd
11 episodes with pharmd
10 episodes with pharmd
11 episodes with pharmd
19 episodes with pharmd
9 episodes with pharmd
19 episodes with pharmd
12 episodes with pharmd
13 episodes with pharmd
14 episodes with pharmd
10 episodes with pharmd
4 episodes with pharmd
20 episodes with pharmd
12 episodes with pharmd
19 episodes with pharmd
22 episodes with pharmd
18 episodes with pharmd
8 episodes with pharmd
6 episodes with pharmd
15 episodes with pharmd
14 episodes with pharmd
8 episodes with pharmd
15 episodes with pharmd
8 episodes with pharmd
6 episodes with pharmd
5 episodes with pharmd
12 episodes with pharmd
12 episodes with pharmd
3 episodes with pharmd
14 episodes with pharmd
8 episodes with pharmd
17 episodes with pharmd
7 episodes with pharmd
6 episodes with pharmd
3 episodes with pharmd
8 episodes with pharmd
6 episodes with pharmd
12 episodes with pharmd
3 episodes with pharmd
7 episodes with pharmd
13 episodes with pharmd
12 episodes with pharmd
6 episodes with pharmd
5 episodes with pharmd
6 episodes with pharmd
9 episodes with pharmd
3 episodes with pharmd
8 episodes with pharmd
5 episodes with pharmd
6 episodes with pharmd
4 episodes with pharmd
4 episodes with pharmd
3 episodes with pharmd
5 episodes with pharmd
5 episodes with pharmd
5 episodes with pharmd
4 episodes with pharmd
9 episodes with pharmd
3 episodes with pharmd
4 episodes with pharmd
6 episodes with pharmd
5 episodes with pharmd
7 episodes with pharmd
4 episodes with pharmd
5 episodes with pharmd
7 episodes with pharmd
6 episodes with pharmd
4 episodes with pharmd
3 episodes with pharmd
7 episodes with pharmd
4 episodes with pharmd
9 episodes with pharmd
10 episodes with pharmd
8 episodes with pharmd
10 episodes with pharmd
8 episodes with pharmd
11 episodes with pharmd
3 episodes with pharmd
4 episodes with pharmd
7 episodes with pharmd
5 episodes with pharmd
2 episodes with pharmd
5 episodes with pharmd
7 episodes with pharmd
2 episodes with pharmd
3 episodes with pharmd
3 episodes with pharmd
3 episodes with pharmd
4 episodes with pharmd
4 episodes with pharmd
4 episodes with pharmd
4 episodes with pharmd
6 episodes with pharmd
3 episodes with pharmd
3 episodes with pharmd
3 episodes with pharmd
3 episodes with pharmd
9 episodes with pharmd
3 episodes with pharmd
3 episodes with pharmd
3 episodes with pharmd
3 episodes with pharmd
2 episodes with pharmd
3 episodes with pharmd
2 episodes with pharmd
5 episodes with pharmd
In this episode, hear Allison Butts, PharmD, BCOP and Danielle Roman, PharmD, BCOP, share their insights on the best practices for incorporating antibody–drug conjugates (ADCs) into clinical practice including:An overview of ADC structure and mechanism of actionA topline review of data supporting the current FDA-approved indications for ADCs targeting HER2 and TROP-2 across multiple tumor typesAn in-depth look at common and serious adverse events with each approved ADC along with an overview of management strategiesEditor's note: On June 23, 2025, the FDA granted accelerated approval for a new indication for datopotamab deruxtecan, one of the antibody drug conjugates discussed in this podcast. Datopotamab deruxtecan is now also approved for adults with locally advanced or metastatic EGFR-mutated NSCLC who have received previous EGFR-targeted therapy and platinum-based chemotherapy. Program faculty:Allison Butts, PharmD, BCOPPharmacist Manager, OncologyClinical Pharmacist, Breast OncologyUK HealthCareMarkey Cancer CenterLexington, KentuckyDanielle Roman, PharmD, BCOPManager, Oncology Clinical Pharmacy ServicesAllegheny Health NetworkPittsburgh, PennsylvaniaProgram page:https://bit.ly/4lr7cT6
Does a 1% AUM fee really cost you 25% of your returns? Tim Ulbrich and Tim Baker run the numbers and give you a framework to evaluate the real cost and the real value of financial planning. Episode Summary YFP Co-Founder & CEO, Tim Ulbrich, PharmD, and YFP Co-Founder & COO, Tim Baker, CFP®, RLP®, RICP®, tackle a common concern about working with a financial advisor: Does paying a 1% fee for assets under management (AUM) really eat away a quarter of your investment gains over time? We run the actual numbers using compound interest calculators to see how much a 1% advisory fee could cost over the long term and whether the 25% claim holds true. But this episode isn't just about math. Tim and Tim also zoom out to look at the bigger picture: What's the ROI of the fee you're paying? Because it's not just about investment returns, it's also about the potential behavioral coaching, tax strategies, withdrawal planning, and comprehensive financial guidance that a good advisor brings to the table. Whether you're a die-hard DIY investor, already working with an advisor, or considering working with a financial planner for the first time, this episode will give you a practical framework to evaluate the real cost and real value of financial advice. Mentioned on the Show YFP YouTube Channel YFP 404: 5 Key Questions to Ask Before Hiring a Financial Planner Vanguard: Putting a value on your value: Quantifying Vanguard Advisor's Alpha® The Investment Funds Institute of Canada. Financial Advice in Canada, November 2022. Kitces Quantifying the Value of Financial Planning Advice Record a Question to be Featured on an Ask YFP Episode Email YFP: info@yourfinancialpharmacist.com
Hypoglycemia can be subtle—or dangerously obvious—and knowing when and how to treat it is critical. In her first episode as our new Push Dose Pearls expert, Emergency Medicine Clinical Pharmacist, Haley Burhans, joins us to break it down. We discuss glucose thresholds by age, when to draw critical labs, and how to choose the right treatment—whether it's oral glucose, IV dextrose, or IM or intranasal glucagon. From neonates to older adults, Haley delivers practical, evidence-based pearls to help you manage low blood sugar safely and effectively in the ED. Was this episode helpful? What other medications would you like to learn more about? Hit us up on social media @empulsepodcast or at ucdavisem.com Hosts: Dr. Julia Magaña, Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Professor of Emergency Medicine at UC Davis Guests: Haley Burhans, PharmD, Emergency Medicine Clinical Pharmacist at UC Davis Resources: Gandhi K. Approach to hypoglycemia in infants and children. Transl Pediatr. 2017 Oct;6(4):408-420. doi: 10.21037/tp.2017.10.05. PMID: 29184821; PMCID: PMC5682370. Rickels MR, Ruedy KJ, Foster NC, Piché CA, Dulude H, Sherr JL, Tamborlane WV, Bethin KE, DiMeglio LA, Wadwa RP, Ahmann AJ, Haller MJ, Nathan BM, Marcovina SM, Rampakakis E, Meng L, Beck RW; T1D Exchange Intranasal Glucagon Investigators. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care. 2016 Feb;39(2):264-70. doi: 10.2337/dc15-1498. Epub 2015 Dec 17. PMID: 26681725; PMCID: PMC4722945.. MD Calc GIR (Glucose Infusion Rate) Calculator **** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.
Dr. Katasha S. Butler, PharmD, MBA, joins The Freedom Forum to share her inspiring rise from a curious grade schooler in Illinois to a senior healthcare leader at Eskenazi Health. With over 20 years of experience, Dr. Butler reflects on her time at Spelman College and Butler University, her rapid ascent into pharmacy leadership, and the challenges she's faced as a Black woman navigating bias in highly regulated systems. She unpacks the complexities of formulary management, regulatory compliance, and strategic partnerships—all while leading with empathy and integrity. From people-first leadership to breaking down barriers in healthcare access and equity, Dr. Butler's story is a powerful testament to purpose, resilience, and the impact of showing up fully and authentically.
On this episode, we evaluate current guidelines and evidence-based strategies for managing chronic pain, including both pharmacologic and non-pharmacologic options. We compare and contrast the efficacy, safety profiles, and appropriate use of various analgesic classes and adjuvant therapies in chronic pain management. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below: www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast.. You can get a copy of HPM at the links below: Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/ If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com
We all know that clinician burnout negatively impacts the quality of patient care. That's why pharmacy residency accrediting bodies now emphasize resident well-being and professional sustainability as core components of residency training earlier in clinician careers. The American Society of Health-System Pharmacists (ASHP) Accreditation Standards for PGY1 and PGY2 Pharmacy Residencies include a formal requirement for programs to address resilience, well-being, and burnout prevention, reflecting the increasing recognition of burnout in healthcare. Joining us to talk that out are Tony Huke, Senior Pharmacy Executive Director with Vizient Pharmacy Advisory Solutions and Kendra Gage, Inpatient Clinical Pharmacist and the PGY 1 Residency Program Director at UCHealth, University of Colorado Hospital in Aurora, Colorado. Guest speakers: Tony Huke, PharmD, BCPS, FASHP Senior Pharmacy Executive Director Vizient Pharmacy Advisory Solutions Kendra Gage, PharmD, BCPS Inpatient Clinical Pharmacist PGY1 Pharmacy Residency Program Director UCHealth Host: Kerry Schwarz, PharmD, MPH Senior Clinical Manager, Evidence-Based Medicine and Outcomes Center for Pharmacy Practice Excellence (CPPE) Show Notes: [01:11-03:25] What's new at the national level in terms of pharmacy resident resiliency and well-being [03:26-03:56] The intentionality of well-being in pharmacy residency programs [03:57-05:12] Examples from Kendra's program [05:13-06:40] Program expectations to address resilience [06:41-08:33] Assessment and potential metrics of resiliency programs [08:34-11:06] The role of pharmacy leadership and residency program directors in resiliency [11:07-12:34] Impact of resiliency programs so far Links | Resources: Accreditation Standards for PGY1 and PGY2 Pharmacy Residencies Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed
Fatty liver disease affects a growing number of patients, often progressing silently until advanced stages. This episode highlights what pharmacists need to know about recent terminology changes, risk factors, pharmacotherapy updates, and key counseling strategies to support patients. Tune in to sharpen your clinical knowledge and help identify, manage, and educate patients at risk for this increasingly common condition. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTSarah Wheeler, PharmD, BCACP, CDCESAssistant ProfessorVCU School of PharmacyPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current terminology, risk factors, and stages associated with fatty liver disease.2. Identify evidence-based pharmacologic and non-pharmacologic strategies that pharmacists can use to support patients with or at risk for fatty liver disease.0.05 CEU/0.5 HrUAN: 0107-0000-25-219-H01-PInitial release date: 6/23/2025Expiration date: 6/23/2026Additional CPE details can be found here.
Fatty liver disease affects a growing number of patients, often progressing silently until advanced stages. This episode highlights what pharmacists need to know about recent terminology changes, risk factors, pharmacotherapy updates, and key counseling strategies to support patients. Tune in to sharpen your clinical knowledge and help identify, manage, and educate patients at risk for this increasingly common condition.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTSarah Wheeler, PharmD, BCACP, CDCESAssistant ProfessorVCU School of Pharmacy Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current terminology, risk factors, and stages associated with fatty liver disease.2. Identify evidence-based pharmacologic and non-pharmacologic strategies that pharmacists can use to support patients with or at risk for fatty liver disease.0.05 CEU/0.5 HrUAN: 0107-0000-25-219-H01-PInitial release date: 6/23/2025Expiration date: 6/23/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Matthew Lunning, DO, FACP Despite FDA approvals and growing clinical integration, CAR T-cell therapies remain clouded by misconceptions, some of which could impact clinical decision-making and delay appropriate referrals. To help set the record straight on CAR T-cell therapy, Dr. Charles Turck speaks with Dr. Matthew Lunning about the realities of patient selection, safety, and access. Dr. Lunning is an Associate Professor in the Division of Hematology/Oncology at the University of Nebraska Medical Center.
Is it Q-var or Q-vair? Find out today. This is the 57th episode in my drug pronunciations series. In the episode, I divide QVAR and beclomethasone into syllables, tell you which syllables to emphasize, and share my sources. The written pronunciations are below and in the show notes on thepharmacistsvoice.com. Note: we don't cover pharmacology in this series. Just pronunciations. QVAR = KUE-var Q, like the letter in the alphabet (Q) Var, which rhymes with “far” Emphasize KUE (Q) Sources: Patient Information in the prescribing information for QVAR on the FDA's website https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207921s000lbl.pdf for the written pronunciation. drugs.com for the spoken pronunciation. Note: the pronunciation of Redihaler is red-ee-HAYE' ler. (It's a combo of “ready” and “inhaler.”) beclomethasone = be-kloe-METH-a-sone Beh, like Becky Kloe, like a 4-leaf clover Meth, like methane A, which is a short “A” sound or a schwa “A” sound. It sounds like “Uh” Sone, similar to “zone” Emphasize METH Sources: MedlinePlus.gov (written) and Dr. Tony Guerra's YouTube channel (spoken) If you'd like to recommend a drug name for this series, please reach out. Either send me a voicemail message or type a message under the contact tab on thepharmacistsvoice.com. If you know someone who would like to learn how to say QVAR Redihaler or beclomethasone, please share this episode with them. Subscribe for all future episodes. This podcast is on all major podcast players and YouTube. Popular links are below. ⬇️ Apple Podcasts https://apple.co/42yqXOG Spotify https://spoti.fi/3qAk3uY Amazon/Audible https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt ⭐️ Sign up for The Pharmacist's Voice ® monthly email newsletter! https://bit.ly/3AHJIaF Host Background: Kim Newlove has been an Ohio pharmacist since 2001 (BS Pharm, Chem Minor). Her experience includes hospital, retail, compounding, and behavioral health. She is also an author, voice actor (medical narrator and audiobook narrator), podcast host, and consultant (audio production and podcasting). Links from this episode Patient Information Section for QVAR on the FDA's website https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020911s029s030lblPI.pdf (accessed 6-18-25) drugs.com - check out the “click and listen” feature MedlinePlus.gov (beclomethasone) https://medlineplus.gov/druginfo/meds/a681050.html Tony Guerra, PharmD on YouTube beclomethasone video The Pharmacist's Voice Podcast Episode 333, Pronunciation Series Episode 56 (pantoprazole) The Pharmacist's Voice Podcast Episode 330, Pronunciation Series Episode 55 (oxcarbazepine) The Pharmacist's Voice Podcast Episode 328, Pronunciation Series Episode 54 (nalmefene) The Pharmacist's Voice Podcast Episode 326, Pronunciation Series Episode 53 (Myrbetriq) The Pharmacist's Voice Podcast Episode 324, Pronunciation Series Episode 52 (liraglutide) The Pharmacist's Voice Podcast Episode 322, Pronunciation Series Episode 51 (ketamine) The Pharmacist's Voice Podcast Episode 320, Pronunciation Series Episode 50 (Jantoven) The Pharmacist's Voice Podcast Episode 318, Pronunciation Series Episode 49 (ipratropium) The Pharmacist's Voice Podcast Episode 316, Pronunciation Series Episode 48 (hyoscyamine) The Pharmacist's Voice Podcast Episode 313, Pronunciation Series Episode 47 (guaifenesin) The Pharmacist's Voice Podcast Episode 311, Pronunciation Series Episode 46 (fluticasone) The Pharmacist's Voice Podcast Episode 309, Pronunciation Series Episode 45 (empagliflozin) The Pharmacist's Voice Podcast Episode 307, Pronunciation Series Episode 44 (dapagliflozin) The Pharmacist's Voice Podcast Episode 304, Pronunciation Series Episode 43 (cetirizine) The Pharmacist's Voice Podcast Episode 302, Pronunciation Series Episode 42 (buspirone) The Pharmacist's Voice Podcast Episode 301, Pronunciation Series Episode 41 (azithromycin) The Pharmacist's Voice Podcast Episode 298, Pronunciation Series Episode 40 (umeclidinium) The Pharmacist's Voice Podcast Episode 296, Pronunciation Series Episode 39 (Januvia) The Pharmacist's Voice Podcast Episode 294, Pronunciation Series Episode 38 (Yasmin) The Pharmacist's Voice Podcast Episode 292, Pronunciation Series Episode 37 (Xanax, alprazolam) The Pharmacist's Voice Podcast Episode 290, Pronunciation Series Episode 36 (quetiapine) The Pharmacist's Voice Podcast Episode 287, pronunciation series ep 35 (bupropion) The Pharmacist's Voice Podcast Episode 285, pronunciation series ep 34 (fentanyl) The Pharmacist's Voice Podcast Ep 281, Pronunciation Series Ep 33 levothyroxine (Synthroid) The Pharmacist's Voice ® Podcast Ep 278, Pronunciation Series Ep 32 ondansetron (Zofran) The Pharmacist's Voice ® Podcast Episode 276, pronunciation series episode 31 (tocilizumab-aazg) The Pharmacist's Voice ® Podcast Episode 274, pronunciation series episode 30 (citalopram and escitalopram) The Pharmacist's Voice ® Podcast Episode 272, pronunciation series episode 29 (losartan) The Pharmacist's Voice Podcast Episode 269, pronunciation series episode 28 (tirzepatide) The Pharmacist's Voice Podcast Episode 267, pronunciation series episode 27 (atorvastatin) The Pharmacist's Voice Podcast Episode 265, pronunciation series episode 26 (omeprazole) The Pharmacist's Voice Podcast Episode 263, pronunciation series episode 25 (PDE-5 inhibitors) The Pharmacist's Voice Podcast Episode 259, pronunciation series episode 24 (ketorolac) The Pharmacist's Voice ® Podcast episode 254, pronunciation series episode 23 (Paxlovid) The Pharmacist's Voice ® Podcast episode 250, pronunciation series episode 22 (metformin/Glucophage) The Pharmacist's Voice Podcast ® episode 245, pronunciation series episode 21 (naltrexone/Vivitrol) The Pharmacist's Voice ® Podcast episode 240, pronunciation series episode 20 (levalbuterol) The Pharmacist's Voice ® Podcast episode 236, pronunciation series episode 19 (phentermine) The Pharmacist's Voice ® Podcast episode 228, pronunciation series episode 18 (ezetimibe) The Pharmacist's Voice ® Podcast episode 219, pronunciation series episode 17 (semaglutide) The Pharmacist's Voice ® Podcast episode 215, pronunciation series episode 16 (mifepristone and misoprostol) The Pharmacist's Voice ® Podcast episode 211, pronunciation series episode 15 (Humira®) The Pharmacist's Voice ® Podcast episode 202, pronunciation series episode 14 (SMZ-TMP) The Pharmacist's Voice ® Podcast episode 198, pronunciation series episode 13 (carisoprodol) The Pharmacist's Voice ® Podcast episode 194, pronunciation series episode 12 (tianeptine) The Pharmacist's Voice ® Podcast episode 188, pronunciation series episode 11 (insulin icodec) The Pharmacist's Voice ® Podcast episode 184, pronunciation series episode 10 (phenytoin and isotretinoin) The Pharmacist's Voice ® Podcast episode 180, pronunciation series episode 9 Apretude® (cabotegravir) The Pharmacist's Voice ® Podcast episode 177, pronunciation series episode 8 (metoprolol) The Pharmacist's Voice ® Podcast episode 164, pronunciation series episode 7 (levetiracetam) The Pharmacist's Voice ® Podcast episode 159, pronunciation series episode 6 (talimogene laherparepvec or T-VEC) The Pharmacist's Voice ® Podcast episode 155, pronunciation series episode 5 Trulicity® (dulaglutide) The Pharmacist's Voice ® Podcast episode 148, pronunciation series episode 4 Besponsa® (inotuzumab ozogamicin) The Pharmacist's Voice ® Podcast episode 142, pronunciation series episode 3 Zolmitriptan and Zokinvy The Pharmacist's Voice ® Podcast episode 138, pronunciation series episode 2 Molnupiravir and Taltz The Pharmacist's Voice ® Podcast episode 134, pronunciation series episode 1 Eszopiclone and Qulipta Kim's websites and social media links: ✅ Guest Application Form (The Pharmacist's Voice Podcast) https://bit.ly/41iGogX ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Business website https://www.thepharmacistsvoice.com ✅ Get my FREE eBook and audiobook about podcasting ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com ✅ Podcasting course https://www.kimnewlove.com/podcasting ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with the same coach who helped me get started (Dave Jackson from The School of Podcasting)! **Affiliate Link - NEW 9-8-23** Thank you for listening to episode 335 of The Pharmacist's Voice ® Podcast. If you know someone who would like this episode, please share it with them!
Feeling financially stuck despite making a good income? Tim Ulbrich, PharmD, unpacks three common reasons pharmacists hit a financial plateau and how to reframe your thinking about money, income, and possibility. Episode Summary Do you ever feel like, despite making a good income, you should be further along financially? You've got the degree, the stable job, the six-figure salary…but you're not making the progress you hoped for. You feel stuck, and you're wondering why. In this episode of the Your Financial Pharmacist Podcast, YFP Co-Founder & CEO Tim Ulbrich, PharmD, explores three common reasons many pharmacists feel financially stuck, even with a strong income: A fixed mindset that limits your financial potential A fixed income that hasn't kept up with inflation or your goals Fixed costs that quietly chip away at your freedom and options This isn't just a conversation about budgeting or side hustles. It's about changing how we think about money, income, and what's possible. Whether you're early in your career or feeling stuck mid-way through, this episode will help you gain clarity and take actionable steps toward financial progress. Mentioned on the Show The Big Leap by Gay Hendricks YFP 384: Beyond Salary: Negotiating Your Value in the Workplace Bureau of Labor Statistics (BLS), Pharmacists Book a Discovery Call with the YFP Team
Tune in to this episode featuring Drs. Neil Skolnik and Sara Wettergreen as they explore the power of storytelling and how it brings us together. Special guests Marlee Seibold and Dr. Saige Kiedinger shared their personal experiences with type 1 diabetes, including— challenges, triumphs, and the everyday moments that have shaped their journeys. We hope that by listening to their stories, you'll gain a deeper understanding of the power of storytelling and feel inspired to share your own journey. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Marlee Seibold: Storytelling Communications Manager at the ADA and a person living with type 1 diabetes. Dr. Saige Kiedinger: A recent pharmacy school graduate transitioning to residency training, also living with type 1 diabetes. Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day! Want to share your journey with us? Share it now here.
Amina Abubakar, PharmD, AAHIVP, joined Over the Counter to discuss her career journey within the pharmacy profession, from her time in big-box retail to owning an independent pharmacy and continuing education institute.
What does the future of cancer care look like? From replacing IV chemo with oral agents to game-changing advances in bispecific and trispecific therapies, this special bonus episode dives deep into the most exciting—and practice-changing—developments from the 2025 ASCO Annual Meeting.NCODA's Kelly Brunk, PharmD, BCOP, returns from ASCO energized and ready to share his top takeaways in a candid conversation about where oncology is headed. Whether you're a clinician, pharmacist, or anyone in the cancer care ecosystem, this episode is packed with insight you don't want to miss.Bonus: Kelly also shares updates on NCODA's new Immunotherapy Hub and offers a forward-looking take on where the field is headed."The rate of change in oncology care is accelerating—and it's time for practices to be ready, not reactive." — Kelly Brunk Inside the Episode:How oral therapies are reshaping breast cancer treatmentThe evolving role of bispecifics, trispecifics, and antibody-drug conjugatesPractical considerations for implementation: protocols, access, and infrastructureThe importance of quality of life in treatment decisionsEarly use of immune checkpoint inhibitors in multiple disease statesHow AI and equity are shaping the next decade of oncology Listen now and explore what these developments mean for clinical practice—and for the patients at the center of it all. Resources mentioned:NCODA's Immunotherapy Hub – A central resource offering clinical tools, SOP examples, and support for implementing therapies like bispecifics and antibody-drug conjugates.Questions or looking to connect? Email the NCODA Clinical Team at clinical@ncoda.org
What if one compound could dramatically reduce allergic reactions, inflammation, and even medication overload for chronically ill individuals? In this episode, pharmacist Bryana Gregory shares the exciting news of a recent publication in the Journal of Independent Medicine spotlighting the repurposed compound Amlexanox. Originally developed to treat mouth ulcers, Amlexanox has shown powerful anti-inflammatory and mast cell-stabilizing effects, making it a promising alternative to steroids and antihistamines, especially for patients suffering from conditions like Mast Cell Activation Syndrome (MCAS), asthma, and autoimmunity. Bryana highlights the dramatic transformation of a 60-year-old guest at the Hotze Health & Wellness Center. This patient, who previously relied on 81 medications and supplements, experienced a significant reduction in symptoms and a tapering down to just 17 medications after introducing Amlexanox. The compound worked to stabilize immune responses, reduce histamine overload, and ease inflammatory symptoms without the side effects commonly associated with steroids. Its broader effects have also included improved blood sugar, brain fog, neuropathy, and even weight loss. With a growing body of evidence and support from independent physicians, Amlexanox is gaining recognition as a trusted, natural solution worth exploring. Watch now and subscribe to our podcasts at www.HotzePodcast.com. For more information about Physician's Preference Pharmacy, please call us at 281-828-9088, or visit https://physicianspreferencerx.com/. To receive a FREE copy of Dr. Hotze's best-selling book, “Hormones, Health, and Happiness,” call 281-698-8698 and mention this podcast. Includes free shipping!
In this episode, Kathy Schott sits down with Dr. Kate Smith, clinical faculty and pharmacy education expert, to explore one of the most critical and challenging aspects of training student pharmacists and residents: developing clinical reasoning skills. Drawing from over a decade of experience in both clinical practice and education, Dr. Smith discusses nuanced differences between clinical reasoning, critical thinking, and problem-solving and offers preceptors practical, classroom-tested strategies to support learners. From using patient cases and SOAP notes to applying the "One Minute Preceptor" model, this episode is a must-listen for any pharmacy educator or preceptor aiming to foster confident, capable, and patient-centered practitioners.HostKathy Schott, PhDVice President, Education & OperationsCEimpactGuestKathryn (Kate) Smith, PharmD, BCACPAssociate Professor of InstructionUniversity of Iowa College of PharmacyGet CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1. Differentiate clinical reasoning from critical thinking and problem-solving2. Identify practical strategies to teach and assess clinical reasoning skills in student pharmacists and residents in experiential settings.0.05 CEU/0.5 HrUAN: 0107-0000-25-215-H99-PInitial release date: 6/18/2025Expiration date: 6/18/2028Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram
In this thought-provoking episode of RxGenius, host Dr. Ryan Paul Liabenow sits down with Nadia Archambault, PharmD—a pharmacist, certified sexual health therapist, and trailblazing entrepreneur—to unpack the often-misunderstood topic of sexual health. Together, they explore why sexual health is far more than just STI prevention and reproductive function. The conversation dives deep into the psychological, emotional, and relational components of sexuality, highlighting how pharmacists and healthcare professionals can better recognize and support the full spectrum of patient needs. Nadia shares her perspective on common misconceptions, the stigma surrounding sexual well-being, and the importance of approaching patient care with sensitivity, curiosity, and respect for diverse experiences. This episode challenges traditional views and emphasizes the essential role sexual health plays in overall well-being. Key Topics Covered: Redefining sexual health beyond disease prevention The mental and emotional dimensions of sexual well-being Pharmacists' roles in normalizing and supporting sexual health conversations Addressing stigma and tailoring care to diverse identities and needs Nadia's journey from pharmacist to sexual health advocate and entrepreneur Tune in to RxGenius for an open, insightful dialogue that will reshape how you think about sexual health in pharmacy and patient care.
On this episode of The Huddle, Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPT, FAPhA, FADCES and Debbie Hinnen, APN, BC-ADM, CDCES, FAAN discuss the importance of medication persistence, how to talk to clients about starting and staying on diabetes medications, and strategies to help clients stay consistent with their medication taking. This episode was made possible with support from Lilly, A Medicine Company.Learn more about the latest in diabetes technology on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsLearn more about the ADCES7 Self-Care Behaviors: Self-Care Tips (ADCES7)References:Kennedy-Martin, T., Boye, K. S., & Peng, X. (2017). Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review. Patient Preference and Adherence, 11, 1103–1117. https://doi.org/10.2147/PPA.S136639McGovern, A., Hinton, W., Calderara, S. et al. A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study. Diabetes Ther 9, 229–242 (2018). https://doi.org/10.1007/s13300-017-0361-5Evans M, Engberg S, Faurby M, Fernandes JDDR, Hudson P, Polonsky W. Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review. Diabetes Obes Metab. 2022; 24(3): 377-390. doi:10.1111/dom.14603Sabaté E., Adherence to Long-Term Therapies: Evidence for Action, 2003, World Health Organization, Geneva, Switzerland.https://www.ama-assn.org/delivering-care/physician-patient-relationship/8-reasons-patients-dont-take-their-medicationshttps://www.npr.org/sections/health-shots/2017/09/08/549414152/why-do-people-stop-taking-their-meds-cost-is-just-one-reasonhttps://www.adces.org/docs/default-source/handouts/adces7/handout_pwd_adces7_takingmedication.pdf?sfvrsn=4e3f6359_13 Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.
In today's episode, supported by Shorla Oncology, we had the pleasure of speaking with Kate Gasparini, PharmD, BCOP, BCPPS, about the use of the oral formulation of imatinib (Imkeldi) for pediatric and adult patients with select leukemias and other malignancies. Gasparini is a pediatric oncology clinical pharmacy specialist at Memorial Sloan Kettering Cancer Center in New York, New York. In our exclusive interview, Gasparini discussed her role as a clinical pharmacy specialist in pediatric oncology, emphasizing her work in patient care, medication reviews, and supportive care. She also noted challenges in administering treatments to patients with dysphagia and emphasized the need for liquid formulations of common therapies. She explained the significance of the availability of the liquid formulation of imatinib, sharing its benefits for patients who struggle with swallowing. Gasparini also addressed potential barriers to accessing this medication, such as insurance coverage limitations, as well as the importance of considering the volume and palatability of liquid formulations to avoid adverse effects and ensure treatment adherence.
In this episode, we explore the Pharm D program at ISU by interviewing one of their current students about the journey they have been on.
In the third edition of a special podcast series, CancerNetwork® spoke with Daniel Morgensztern, MD; Mary Ellen Flanagan, NP; and Janelle Mann, PharmD, BCOP, about optimal strategies for incorporating different therapeutic agents into lung cancer care. As part of the latest discussion, the group highlighted the relevant efficacy data, administration protocols, and toxicity management considerations associated with TROP2-directed antibody-drug conjugates (ADCs) in patients with non–small cell lung cancer (NSCLC). Morgensztern is a professor of Medicine and the clinical director of Thoracic Oncology in the Division of Oncology at Washington University School of Medicine in St. Louis. Flanagan is a nurse practitioner in the Division of Thoracic Oncology at Washington University. Mann is a clinical oncology pharmacist at Siteman Cancer Center of Washington University School of Medicine and manager of Clinical Pharmacy Services at Barnes-Jewish Hospital. Morgensztern opened the discussion by highlighting the characteristics of prominent TROP2-targeting ADCs in NSCLC management, which included sacituzumab govitecan-hziy (Trodelvy), datopotamab deruxtecan-dlnk (Datroway), and sacituzumab tirumotecan (sac-TMT). Additionally, he reviewed data from clinical trials assessing these ADCs across different NSCLC populations, including the phase 3 EVOKE-01 trial (NCT05089734) showing a numerical overall survival (OS) improvement with sacituzumab govitecan vs docetaxel. Regarding the safety profiles of these ADCs, Flanagan described the unique toxicities associated with the agents' payloads as well as potential off-target effects. On top of myelosuppression, fatigue, and diarrhea, she stated that these therapies may cause more visceral organ toxicities like keratitis of the eye and interstitial lung disease. According to Flanagan, some prophylactic measures in the event of certain toxicities include frequent salt and baking soda mouth rinses as well as oral dexamethasone. Mann then outlined the dosing variability considerations and supportive care measures surrounding the use of agents like sacituzumab govitecan. She emphasized continuously re-educating patients about expected toxicities and supportive care strategies as they undergo these infusion-based therapies to help avoid surprise instances of ocular toxicity, diarrhea, and other adverse effects. Reference Paz-Ares LG, Juan-Vidal O, Mountzios GS, et al. Sacituzumab govitecan versus docetaxel for previously treated advanced or metastatic non-small cell lung cancer: the randomized, open-label phase III EVOKE-01 study. J Clin Oncol. 2024;42(24):2860-2872. doi:10.1200/JCO.24.00733
When it comes to the airway, roc rocks and succ sucks, right? You've heard it more than once. But EMRA*Cast host Peter Lorenz, MD, presents a nuanced argument in defense of succinylcholine, with guests Mike Perza, PharmD, and Patricia Simmer, MD.
Episode 367: Pharmacology 101: PARP Inhibitors “We know that in cells that are proliferating very quickly, including cancer cells, single-strand DNA breaks are very common. When that happens, these breaks are often repaired by the PARP enzyme, and the cells can continue their replication process. If we block PARP, that repair cannot happen. So in blocking that, these single-strand breaks then lead to double-strand breaks, which ultimately is leading to cell apoptosis,” Danielle Roman, PharmD, BCOP, manager of clinical pharmacy services at the Allegheny Health Network Cancer Institute in Pittsburgh, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the PARP inhibitor drug class. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 13, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the use of PARP inhibitors in cancer care. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episodes: Pharmacology 101 series Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs Episode 232: Managing Fatigue During PARP Inhibitor Maintenance Therapy Episode 227: Biomarker Testing, PARP Inhibitors, and Oral Adherence During Ovarian Cancer Maintenance Therapy ONS Voice articles: PARP Inhibitors and Ovarian Cancer Genomics May Trick PARP Inhibitors to Treat More Cancers Oncology Drug Reference Sheet: Niraparib ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Safe Handling of Hazardous Drugs (fourth edition) ONS courses: Safe Handling Basics Clinical Journal of Oncology Nursing articles: PARP Inhibition: Genomics-Informed Care for Patients With Malignancies Driven by BRCA1/BRCA2 Pathogenic Variants Talazoparib Plus Enzalutamide in Patients With HRR-Deficient mCRPC: Practical Implementation Steps for Oncology Nurses and Advanced Practice Providers Oncology Nursing Forum article: Familiarity and Perceptions of Ovarian Cancer Biomarker Testing and Targeted Therapy: A Survey of Oncology Nurses in the United States Oral Anticancer Medication Care Compass: Resources for Interprofessional Navigation ONS Biomarker Database ONS Oral Anticancer Medication Learning Library ONS Oral Anticancer Medication Toolkit Oral Chemotherapy Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “The big toxicities here to watch for are primarily hematologic toxicities. It is one of those targeted therapies that does affect blood cell counts. So I'd say the blood cell count that is most commonly affected here is the hemoglobin. So, anemia very frequent complication that we see, probably a little bit more with olaparib compared with other drugs, but we see it as a class side effect. And we can also see neutropenia and thrombocytopenia with these agents, probably a little bit more with niraparib versus the others, but again, you can see it across all of these drugs.” TS 8:16 “We mentioned that rare risk of MDS and AML. This isn't a particularly scary thing if you talk to patients about it. Because of the rarity that we see this, it isn't something that we need to overemphasize, but I think careful monitoring of blood counts in is stressing the importance of that and early intervention here is very important.” TS 16:55 “This is a collaborative effort. And because of the home administration here, these patients do need to be followed very closely. So we are not laying eyes on them usually with the frequency that we do when we have patients actually coming into our infusion centers for treatments—so making sure that there is a plan for regular follow-up with these patients to ensure that they're getting that lab work done, that that's being looked at closely, that we're adjusting the dose if we need to based on that lab work, that we are managing the patient's fatigue. Again, that potentially dose reductions may be needed if patients are having that extreme fatigue.” TS 19:34 “I think one of those [misconceptions] could be that they're only effective in patients that have that BRCA1/2 mutation. And again, remember here that there is some data in particular disease states that we can use them and that they work in the absence of those mutations.” TS 25:12
This is the 12th episode in my Pharmacist Podcasters Series. My guests and I talk about podcasting to inspire you to start your own podcast, be a podcast guest, or use your voice in general. If you're interested in podcasting, pod-guesting or public speaking, you need to listen to this episode (and the Series!). My guest today is Cory Jenks, PharmD, co-host of the Diabetes Remission Roadmap Podcast. Click to read the FULL show notes: https://www.thepharmacistsvoice.com/podcast (select episode 334) Background information for Dr. Cory Jenks and Dr. Brian Bisher (April 2025) Brian Bisher and Cory Jenks are the co-hosts of The Diabetes Remission Roadmap, a podcast dedicated to cutting through the noise and helping people take real steps toward reversing type 2 diabetes. With their years of pharmacy and wellness experience, they share practical strategies, patient stories, and expert insights to guide listeners toward lasting health without relying on more medications to control their blood sugar. Blending medical expertise with real-life experience, Cory and Brian focus on what actually works—not what's trendy or overly complicated. Their mission is simple: help people reclaim their health through deliberate, sustainable lifestyle changes. With humor, heart, and a heavy dose of common sense, they're proving that remission is possible—and practical. Share this episode! If you know someone who might like The Diabetes Remission Roadmap Podcast, please share this episode with them. Subscribe to or follow The Pharmacist's Voice ® Podcast on your favorite podcast player and YouTube to get each new episode when it comes out. Apple Podcasts https://apple.co/42yqXOG Spotify https://spoti.fi/3qAk3uY Amazon/Audible https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt Thank you for listening today. Happy Father's Day if you're a Dad or a Dad-to-be! This episode was recorded in April 2025 and published on Friday, June 13, 2025 (Father's Day weekend). If you need help starting your podcast, I can help. Get my FREE eBook or audiobook version on kimnewlove.com/podcasting or Amazon https://amzn.to/4iAKNBs. I also teach a self-paced, online course and work with clients by-the-hour. Listen to the episodes about podcasting in my back catalog on thepharmacistsvoice.com/podcast. Links from this episode Brian LI: https://www.linkedin.com/in/brianbisher/ Cory LI: https://www.linkedin.com/in/cory-jenks-3ba17314/ Podcast: https://open.spotify.com/show/5aPdA0uG9GGoTnM7VicLqj?si=a71454aee0544c52 IG: https://www.instagram.com/diabetesremissionpartners/ FB: https://www.facebook.com/Diabetesremissionpartners Cory's 1st book: Permission to Care: Building a Healthcare Culture That Thrives in Chaos https://amzn.to/44C5Zjf Cory's 2nd book: I Guess I'm a Dad Now: A Humorous Handbook for New-Ish Dads Who Don't Want to Suck https://amzn.to/3SP5EpK The Pharmacist's Voice Podcast Episode 89 featuring Cory Jenks, PharmD https://bit.ly/3fdZIDR The Pharmacist's Voice Podcast Episode 230 featuring Cory Jenks, PharmD https://bit.ly/3JQIoUd The Pharmacist's Voice Podcast Episode 183 featuring Brian Bisher, PharmD https://bit.ly/3zoIKvO Pharmacist Podcasters Series Part 1 with Ola Latala, PharmD (The Pharmacist's Voice Podcast Episode 248) Part 2 with Deeb Eid, PharmD (The Pharmacist's Voice Podcast Episode 253) Part 3 with Justin Cole, PharmD (The Pharmacist's Voice Podcast Episode 257) Part 4 with Christina Fontana, PharmD The Pharmacist's Voice Podcast Episode 262 Part 5 with Tony Dao, PharmD The Pharmacist's Voice Podcast Episode 266 Part 6 with Dr. H (Hussam Hamoush, PharmD) The Pharmacist's Voice Podcast Episode 275 Part 7 with Julie Doan, PharmD The Pharmacist's Voice Podcast Episode 297 Part 8 with Tim Ulbrich, PharmD The Pharmacist's Voice Podcast Episode 306 Part 9 with Zain Syed, PharmD The Pharmacist's Voice Podcast Episode 310 Part 10 with Rachel Gainsbrugh, PharmD The Pharmacist's Voice Podcast Episode 323 Part 11 with Danielle Plummer, PharmD The Pharmacist's Voice Podcast Episode 329 Part 12 with Cory Jenks, PharmD (TODAY!) Kim's websites and social media links: ✅ Guest Application Form (The Pharmacist's Voice Podcast) https://bit.ly/41iGogX ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF ✅ LinkedIn Newsletter https://bit.ly/40VmV5B ✅ Business website https://www.thepharmacistsvoice.com ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Pronounce Drug Names Like a Pro © Online Course https://www.kimnewlove.com ✅ FREE Podcasting eBook/audiobook combo https://www.kimnewlove.com/podcasting ✅ Podcasting Online Course https://www.kimnewlove.com/podcasting ✅ Private Podcasting Coaching or Consulting https://www.kimnewlove.com/private-coaching ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with the same coach who helped me get started (Dave Jackson from The School of Podcasting)! **Affiliate Link - NEW 9-8-23** Thank you for listening to episode 334 of The Pharmacist's Voice ® Podcast. If you know someone who would like this episode, please share it with them!
In this special Father's Day episode, Tim Ulbrich shares five unexpected and powerful money lessons he's learned from raising four boys. Episode Summary YFP Co-Founder & CEO, Tim Ulbrich, PharmD, reflects on the unexpected and powerful financial lessons he's learned from raising four boys. From conversations at the concession stand to big-picture reflections on priorities, Tim shares 5 meaningful insights that go beyond spreadsheets and savings accounts. Whether you're a parent, planning to be one, or simply interested in how life shapes our money mindset, this episode offers a personal and practical look at the intersection of fatherhood and finance. Mentioned on the Show YFP 363: A Conversation with My Dad: Lessons on Entrepreneurs, Fatherhood, and Finance YFP 402: Building a Legacy: The Family Constitution Blueprint with Julia Myers Die With Zero: Getting All You Can From Your Money and Your Life by Bill Perkins Happy Money: The Science of Happier Spending by Elizabeth Dunn and Michael Norton
Episode 053 | Dr. Marthe Dika, MD, FAAD is a board-certified dermatologist and proud owner of M. Dika Dermatology, with practices located in Burlington and Glendale, Wisconsin. At her clinics, she welcomes patients of all ages and skin types, offering comprehensive care for diseases of the skin, hair, and nails. Dr. Dika is particularly experienced in and passionate about managing hair loss and has helped many people who struggle with this often devastating problem.In addition to her clinical work, Dr. Dika is involved in advancing the field ofdermatology through clinical trials conducted at her two locations. Her dedication to research allows her to remain at the forefront of dermatologic advancements and offer her patients cutting edge treatment options.She earned her medical degree from the Medical College of Wisconsin in Milwaukee and completed her residency in dermatology at the University of Iowa. Dr. Dika's commitment to patient care coupled with her passion for dermatology ensures that all who visit M. Dika Dermatology receive the highest quality care tailored to their individual needs.Shout out to Dr. Dika's mentor, Dr. Chesahna Kindred, as mentioned in this episode! Thanks to all the great mentors out there for all that you do. And shout out to the absolutely delightful Whitney Hubbell, PharmD, IBCLC. Dr. Hubbell is currently an all-star Medical Science Liaison at Sanofi, and I'm grateful to her for introducing me to Dr. Dika.This episode was recorded on February 3rd, 2025.Connect with and learn from Dr. DikaM. Dika DermatologyInstagramFacebookMore from Dr. Lewellis and Above & Beyond DermatologyNeed a dermatologist? Fill out this short interest form, text or call me at 715-391-9774, or email me at drlewellis@aboveandbeyondderm.com if you'd like to have a no obligation discovery call. I offer in-office visits, house calls, and virtual care in Wisconsin and virtual care in Illinois, Nebraska, and Colorado.Have an idea for a guest or want to be on the show yourself? Send me a text or email, and we'll see if it's a good fit.Above & Beyond DermatologyNutrafol -- special pricing and physician exclusive productsNeoGenesis -- my favorite source of stem cell released molecules for skin/hairSilagen.biz -- physician dispensed scar refinement products delivered to your door (use practice code 1206240832P)NewsletterLinkedInFacebookDr. Lewellis on InstagramAbove & Beyond Dermatology on InstagramYouTubeTikTokTwitter/XChange Your Mind, Change Your LifeSoMeDocs (Doctors on Social Media)Pippa!
Information on COVID vaccines is moving fast. On May 27th, HHS Secretary Robert F. Kennedy Jr. announced that COVID vaccines will no longer be universally recommended for healthy children or healthy pregnant women. That's a big shift, and understandably, it's raised a lot of questions. We're going to cut through the noise and take a look at where things really stand, who's getting vaccinated, how current guidance is evolving, and what this means for both children and adults as we look ahead to the next respiratory season. Joining us to help sort it all out is Dr. John Schoen, Senior Clinical Manager of Drug Information at Vizient. Guest speakers: John Schoen, PharmD, BCPS Senior Clinical Manager of Drug Information Vizient Center for Pharmacy Practice Excellence Host: Stacy Lauderdale, PharmD, BCPS Associate Vice President Vizient Center for Pharmacy Practice Excellence Show Notes: [01:38-05:32] What changed in the recent CDC update for healthy children [05:33-09:32] Discussion of COVID-19 outcomes and vaccination in children [09:33-11:47] Specific risk factors for pediatric patients [11:48-12:47] Is the US an outlier for not universally recommending the COVID-19 vaccine for healthy children and making no recommendation in healthy pregnant women? [12:48-14:03] The FDA's proposed regulatory framework for COVID-19 vaccine approval [14:04-15:18] FDA's approach to implementing revised requirements for randomized controlled trials [15:19-16:57] Key discussion points from the May meeting of the Vaccines and Related Biological Products Advisory Committee [17:00-18:27] Topics requiring further clarification about COVID-19 vaccine Links | Resources: Vizient resources: Minute Market Insight: Potential ACIP COVID-19 recommendation changes April 2025: https://www.vizientinc.com/download?342668 Minute Market Insight: May 2025 COVID-19 vaccine recommendation and policy updates: https://www.vizientinc.com/download?352336 Additional resources: FDA perspective piece published in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMsb2506929 ACIP meeting information: https://www.cdc.gov/acip/meetings/index.html CDC childhood immunization schedule: https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age.html CDC adult immunization schedule by medical condition: https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html CDC RESP-NET: https://www.cdc.gov/resp-net/dashboard/ WHO COVID-19 dashboard: https://data.who.int/dashboards/covid19/deaths MMWR - COVID-19–Associated Hospitalizations and Maternal Vaccination Among Infants Aged
Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Over the Counter to discuss the potential impact pharmaceutical tariffs may have on pharmacies if they are to be widely implemented in the near future.
Eczema is on the rise and many people are running out of treatment options. In this episode, pharmacist Bryana Gregory dives into the real reasons behind the growing number of eczema cases and why standard treatments like steroid creams or biologic drugs may not be the answer. From identifying common triggers like allergens, stress, and even spike proteins, to understanding how compromised skin leads to deeper immune issues, Bryana explains how eczema is more than just a skin condition, it's a cry for help from within. You'll also learn about a proprietary topical formulation created by Physicians Preference Pharmacy, designed to strengthen the skin barrier, reduce inflammation, and provide relief without the harmful side effects of long-term steroid use. With ingredients like ivermectin, zinc pyrithione, hydrocortisone (or a cortisone-free option), and low-dose naltrexone, this treatment offers a personalized, root-cause approach that's helping both children and adults reclaim their comfort and confidence. Watch now and subscribe to our podcasts at www.HotzePodcast.com. For more information about Physician's Preference Pharmacy, please call us at 281-828-9088, or visit https://physicianspreferencerx.com/. To receive a FREE copy of Dr. Hotze's best-selling book, “Hormones, Health, and Happiness,” call 281-698-8698 and mention this podcast. Includes free shipping!
Tripp Logan, PharmD, and Richard Logan, Jr., PharmD, join us in this episode of the “Independent Rx Forum” to discuss care coordination –– a vital but often overlooked role of community pharmacy that, at some level, every pharmacy is already doing. From ensuring patients receive their medications on time to closing care gaps, pharmacies are a trusted touchpoint in the health care system. Learn what funding opportunities are out there and how to raise awareness with payers. Guests: Tripp Logan, PharmD, Luminary, CPESN Missouri, Richard Logan, Jr., PharmD
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: John Koo, MD As the array of novel therapies for plaque psoriasis expands, a strategy to navigate treatment options is to focus on the specific needs of different patient groups, like Medicare-aged patients. ILUMYA® (tildrakizumab-asmn) is the only biologic for plaque psoriasis guaranteed to be covered under the medical benefit of Medicare, with no prior authorization and zero cost as a likely possibility. Join Dr Charles Turck and Dr John Koo as they share insights on the efficacy, safety, and accessibility of ILUMYA in this patient population. Dr. Koo is a Professor of Dermatology at the University of California at San Francisco School of Medicine.
On this episode of Managed Care Cast, The American Journal of Managed Care® speaks with Julia Lucaci, PharmD, MS, the senior director of global health economics and outcomes research at Becton, Dickinson and Company (BD), an international medical technology company. Her commentary, "Should Payers Incentivize Pharmacies to Blister-Package Chronic Medications?" argues that payers should consider offering higher reimbursement rates and/or preferred network status to pharmacies that dispense chronic medications in blister packs to enhance medication adherence and patient outcomes. During the conversation, Lucaci explores the widespread impact of medication nonadherence, the benefits and underutilization of blister packaging in the US, and strategies that could support broader adoption to improve chronic disease management and lower overall health care costs.
I sat down with Tim Ulbrich, PharmD, Co-Founder and CEO of Your Financial Pharmacist, to unpack a tough reality: why so many pharmacists earning six figures still feel broke. We dug into crushing student debt, soaring housing costs, wage stagnation—and the mindset shift needed to build real financial freedom. Tim brings clarity, strategy, and hope. This episode is sponsored by Remedichain.
Creatine is often associated with athletic performance, but growing evidence points to its broader benefits for brain health, aging, and overall muscle preservation. This episode breaks down what pharmacists need to know about creatine's evidence-based uses, safety considerations, and counseling opportunities. Tune in to strengthen your knowledge and help ensure patients receive accurate, evidence-based information about this widely used supplement. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTMark Smith, PharmD, CDCES, AFAA-CGFIPharmacistUAB MedicineIan Haywood, PharmD, BCPS, CDCESClinical PharmacistBaptist Memorial HospitalPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the evidence-based uses of creatine beyond athletic performance, including its potential benefits for brain health and aging.2. Identify key counseling points for pharmacists when discussing creatine supplementation with patients.0.05 CEU/0.5 HrUAN: 0107-0000-25-200-H01-PInitial release date: 6/9/2025Expiration date: 6/9/2026Additional CPE details can be found here.
Creatine is often associated with athletic performance, but growing evidence points to its broader benefits for brain health, aging, and overall muscle preservation. This episode breaks down what pharmacists need to know about creatine's evidence-based uses, safety considerations, and counseling opportunities. Tune in to strengthen your knowledge and help ensure patients receive accurate, evidence-based information about this widely used supplement. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTMark Smith, PharmD, CDCES, AFAA-CGFIPharmacistUAB MedicineIan Haywood, PharmD, BCPS, CDCESClinical PharmacistBaptist Memorial Hospital Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the evidence-based uses of creatine beyond athletic performance, including its potential benefits for brain health and aging.2. Identify key counseling points for pharmacists when discussing creatine supplementation with patients.0.05 CEU/0.5 HrUAN: 0107-0000-25-200-H01-PInitial release date: 6/9/2025Expiration date: 6/9/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
Send us a textIn this graduation season compilation on “The UMB Pulse,” hear from three of the visionary leaders who spoke directly to the University of Maryland, Baltimore's Class of 2025 — and to anyone entering a world that desperately needs bold, ethical leadership. · Paul A. Offit, MD '77, director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at the Children's Hospital of Philadelphia and the Maurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania, opens with a personal and historical reminder of why public trust in science — and vaccines — must be protected at all costs. (05:36) · Zach Noel, PharmD, PhD '23, BCC, associate professor at the University of North Carolina Eshelman School of Pharmacy, brings heartfelt storytelling and humor to the stage, challenging graduates to choose their “auxiliary labels” wisely and live their values with purpose. (21:09)· Sherrilyn Ifill, JD, the Vernon Jordan Distinguished Professor in Civil Rights and founding director of the 14th Amendment Center for Law & Democracy at Howard University School of Law, closes with a profound call to action — urging law graduates to become the next generation of founders and framers, rebuilding a democracy in crisis. (31:10)Listen to The UMB Pulse on Apple, Spotify, Amazon Music, and wherever you like to listen. The UMB Pulse is also now on YouTube.Visit our website at umaryland.edu/pulse or email us at umbpulse@umaryland.edu.
This episode of the Astonishing Healthcare podcast highlights two recent posters presented by Zachary Brunko, PharmD (PGY1 Managed Care Pharmacy Resident), and Nash Albadarin, PharmD, MBA (Associate Director, Clinical Programs Business Development), at AMCP 2025 and the 2025 PQA Annual Meeting, respectively. We won't give away the conclusions, but Zach explains the team's research on International Classification of Diseases (ICD) codes and how they evaluated the accuracy and reliability of ICD codes submitted on pharmacy claims. Additionally, they sought to identify patterns in ICD code submissions across client types, drug classes, disease states, pharmacy networks, and regions.Nash highlights how text messaging and pharmacist outreach to patients through Rx Enhance - a clinical program designed to improve adherence and close gaps in care - drove marked improvement in medication adherence in 2024 for commercial plan members with diabetes, hypertension, and high cholesterol. If you're interested in the potential to streamline processes and improve decision-making by using data like ICD codes, or the potential for tech-enabled clinical programs to improve health outcomes, this episode is for you!Reference Materials & Related ContentPoster: Evaluating ICD Codes on Pharmacy Claim Submissions: Are They Reliable?Poster: The Impact of Text Messaging and Pharmacist Outreach Interventions on Medication Adherence Rates in a Commercial PBM PopulationAH043 - Pharmacy Benefits 101: DMP & MTM, Explained, with Nash Albadarin, PharmDAH035 - Pharmacy Benefits 101: Clinical Programs, with Bonnie Hui-Callahan, PharmDAH006 - Pharmacy Benefits 101: Clinical Care Teams, with Amy Stockton, PharmDPlease visit Capital Rx Insights for more information, including this episode's transcript!
What mindset separates high earners from true wealth builders? Inspired by The Millionaire Next Door by Dr. Thomas Stanley, Tim Ulbrich breaks down how changing his perspective on money transformed his financial path, and how it can do the same for you. Episode Summary YFP Co-Founder & CEO, Tim Ulbrich, PharmD explores the key mindset shift that helps pharmacists quietly build lasting wealth. This isn't about flashy cars or overnight success. It's about the habits, discipline, and mindset millionaires use to build wealth quietly and consistently. Drawing from both personal experience and lessons from The Millionaire Next Door by Dr. Thomas Stanley, he shares how pharmacists and other high-income earners can adopt a wealth-building mindset that prioritizes financial independence over lifestyle inflation. Whether you're just getting started or looking to level up, this episode will challenge how you think about money and give you the tools to create lasting change. In this episode, you'll learn: The mindset millionaires adopt (that most people don't) Why high income doesn't guarantee financial freedom How to build money habits that grow wealth over time What these insights mean for pharmacists and other professionals pursuing financial independence Mentioned on the Show First Horizon's Pharmacist Home Loan Your Financial Pharmacist The Millionaire Next Door by Dr. Tom Stanley I Will Teach You to be Rich by Ramit Sethi The Compound Effect by Darren Hardy
Daniel O'Neil, PharmD, MS, FASHP, is the Assistant Vice President of Pharmacy Services at WVU Medicine.We talk through building a technology philosophy for the pharmacy enterprise and you'll hear the direction WVU has taken. You'll also learn pathways and tips to be successful in justifying new technology!
Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginAccording to the Centers for Disease Control and Prevention (CDC), diabetes is about 17% more prevalent in rural areas than urban ones. With rural communities often facing barriers to accessing healthcare, including limited specialists and transportation. But what if there was a way to increase rural patient access to specialists? In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP® and Bonnie Bond, CPA talk with Leanna Schwend, PharmD, DCES, owner of Yellowstone Pharmacy in Montana and founder of SugarBEAT for a powerful conversation on turning personal adversity into clinical innovation.After being diagnosed with type 1 diabetes just before graduating pharmacy school, Leanna's career trajectory transformed leading her to create one of the only certified diabetes education programs in a Montana retail pharmacy.Now, she's helping patients and other pharmacy owners bridge gaps in diabetes care, education, and revenue generation.This episode explores:The story behind Leanna's diagnosis and how it changed her missionBuilding and sustaining a certified diabetes education programCreating a digital support platform for patients, caregivers, and pre-diagnosis educationRevenue options: cash-based models vs. accredited servicesAnd more!More About Our Guest:Leanna Schwend is PharmD and independent pharmacy owner who is passionate about Health and Wellness beyond the prescription. Her expertise is in value-added clinical services and leadership with special interests in Diabetes Education, Pharmacogenomics, Nutrigenomics, the Endocannabinoid system, Mental Health, and so much more! Leanna graduated with a Doctor of Pharmacy of degree from the University of Montana Skaggs School of Pharmacy in 2011. She then stepped into the role of Pharmacist in Charge and manager of her family pharmacy, Yellowstone Pharmacy of Forsyth, and became CEO/Owner in 2022.She has successfully implemented an accredited diabetes education program through the American Association of Diabetes Care and Education Specialists, immunizations, medication synchronization, medication therapy management, and pharmacogenomics testing and consulting.She is a Diabetes Care and Education Specialist, holds a certification in Pharmacogenomics, and is a Montana Pharmacy Association Board of Directors.When Leanna turned 25, she was diagnosed with Type 1 diabetes. Through her own personal experiences and knowledge of living with diabetes, she is committed and devoted to educating individuals that they can do more than survive…they can THRIVE! In 2023, Leanna founded SugarBEAT Enterprise, in which she and her teammates aim to deliver a top-notch digital diabetes education solution that will empower individuals on their wellness journey.Learn more about Leanna and SugarBEAT:Leanna Schwend, PharmD, DCES LinkedInSugarBEAT WebsiteSugarBEAT FacebookSugarBEAT InstagramSugarBEAT LinkedInMore resources on this topic:Podcast - Driving Independent Pharmacy Profitability in 2025
On this episode, we evaluate current guidelines and evidence-based treatment strategies for managing GAD. We define generalized anxiety disorder (GAD) and describe its clinical presentations, diagnostic criteria, and underlying pathophysiology. We also compare and contrast the efficacy, safety profiles, and appropriate use of anxiolytic medications, cognitive behavioral therapy, and lifestyle modifications in treating GAD. Dr. David Osser's Website: https://psychopharm.mobi/algo_live/ Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below: www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast.. You can get a copy of HPM at the links below: Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/ If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com
Stacy Bruce, PharmD is a pharmacist in Alabama. Listen to her list of accomplishments with speaking and how she got to where she is today. Her roles at the hospital place her in numerous public speaking situations. She is a member of two Toastmasters clubs. Stacy spoke with me at the SHAA convention in Birmingham in February, 2025. She recently participated in a panel discussion about stuttering with graduate students in SLP. We discuss a holistic approach using CBT and SLP.
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Joseph E. Patruno, MD From delayed diagnosis to chronic pain and fertility issues, endometriosis presents a range of challenges that require individualized attention. By focusing on each patient's unique symptoms and priorities, we can better tailor care and improve outcomes. Join Dr. Mary Katherine Cheeley as she speaks with Dr. Joseph Patruno, an OB/GYN at Lehigh Valley Jefferson Health Network, about practical strategies for delivering comprehensive, patient-centered care.
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP In addition to heavy menstrual bleeding, patients with uterine fibroids often deal with many other considerable effects on their physical and mental wellbeing. To provide optimal care, it's important to recognize the full impact of fibroids, communicate carefully about treatment options, and promote equitable access to care. Dr. Charles Turck sits down with Dr. Ayman Al-Hendy to learn more about how we can address the multifaceted burden of uterine fibroids. Dr. Al-Hendy is a Professor of Obstetrics and Gynecology and the Director of Translational Research at the University of Chicago Pritzker School of Medicine.
Webinar from the National Celiac Assocaition: Gut-Brain Health and Celiac Disease: Caring for Your Second “Brain"Jun 6, 2025 01:00 PM in Eastern TimeJoin the National Celiac Association for their Spring 2025 webinar in the “From the Experts” series. Speakers will present on selected topics for 60 minutes, followed by 15 minutes for Q&A, on Friday, June 6, 2025 from 1-2:15 pm ET.Dr Alessio Fasano, MD, Director of the Mucosal Immunology and Biology Research Center at Mass General for Children; Professor of Pediatrics at Harvard Medical School; and Professor of Nutrition at T.H. Chan School of Public Health, will speak about the “crosstalk” between the gut microbiome and the brain, focusing on developmental disorders and mental health issues in the context of gluten-related disorders. Deanna Kelly, PharmD, BCPP, the Dr. William and Carol Carpenter Professor in Psychiatry for Mental Illness at the University of Maryland School of Medicine and Director and Chief of the Treatment Research Program at the Maryland Psychiatric Research Center, will share her research on schizophrenia, anxiety, and depression, which are often diagnosed as part of the impressive range of celiac disease symptoms.Register here: https://partners.zoom.us/webinar/register/WN_NtbsSjn7TqCVOEUxY2t_cQ?mc_cid=6f22c46ae9#/registrationI would love to hear from you! Leave your messages for Andrea at contact@baltimoreglutenfree.com and check out www.baltimoreglutenfree.comInstagramFacebookGluten Free College 101Website: www.glutenfreecollege.comFacebook: http://www.Facebook.com/Glutenfreecollege Hosted on Acast. See acast.com/privacy for more information.
I sat down with Benjamin Jolley, a third-generation pharmacist who recently addressed a crowd of 20,000 about the broken world of PBMs. We dug into the power of that moment, the hidden mechanics of pharmacy monopolies, and what real reform could look like. This one hits where policy meets reality.
Today's episode dives into something that's frankly underestimated and not talked about enough: women's health. Not only are women underrepresented in clinical studies, but they're frequently told that their suffering is either “normal” or “all in their head.” Or they're prescribed a bunch of pharmaceuticals that haven't been extensively studied in their bodies, especially for long-term effects. My guest today believes that when women's health is optimized, they can GIVE 100% to their daily tasks and FIND MORE JOY in life. It's that simple. And women's health is intimately connected to their hormones, emotions, and their menstrual cycles. So let's stop making menstrual health a taboo subject, and make it a priority instead. Dr. Robinson always felt a calling to help others in the area of health and wellness. At the age of 9, she was diagnosed with a rare autoimmune disease that was put into remission using conventional medicine. She never forgot the kindness shown by her doctors and wanted to ‘pay it forward'. This passion for health took her to the medical field. She graduated with a Doctor of Pharmacy degree from St. Louis College of Pharmacy in 2011 and began working for the U.S. Army as a pharmacist. Upon completing her time in the service, she began working for CVS pharmacy in 2017. In 2020, Dr. Robinson was introduced to the world of Functional Medicine. Within a few months, she achieved certification as a practitioner through Functional Medicine University, quit her job at CVS and branched out on her own. All this time, she recognized there were still some unresolved issues in her health. Using a holistic approach, she started doing the work, seeing results and helping others do the same. She currently owns a 1-on-1 practice where she inspires, educates and coaches women to the healthiest version of themselves. Connect with Nicole via: Email: drrobinson@wentzvillesynergyfm.com Website:Lucerna Functional Medicine FB:Lucerna Functional Medicine IG:@drrfunctionalmed Linked In: Nicole (Mennemeier) Robinson Link to my "No More Period Pain" guide- https://www.canva.com/design/DAGb0yGxWiE/K4Pv-SGOo-rHHDs_koyyEw/view?utm_content=DAGb0yGxWiE&utm_campaign=designshare&utm_medium=link2&utm_source=uniquelinks&utlId=h3d0149e26b
In this second installment of our Data Deep Dive, Shane Turner reconnects with Ken Kasica, who specializes in cardiovascular pharmacology at Abiomed. The two dissect the complex interactions between drug therapies and the Impella heart pumps in critical care. Learn about the impact of vasoconstrictive drugs such as levosimendan and norepinephrine on Impella performance, and studies that highlight the risks associated with high doses of inotropes and vasopressors. This episode provides essential insights for transport clinicians on managing patients with these medications, including strategies from heart teams at destination centers for device escalation, and the latest advancements in the field.In this episode:Shane Turner, RN, CFRN, NRP, FP-C, CMTE, Chattanooga, TN, AbiomedKen Kasica, PharmD, MBA, Director, Scientific Intelligence, Abiomed
What should you do with an old 401(k)? Tim Ulbrich and Tim Baker explore your options, common pitfalls, rollover strategies, and how to make smart moves with old retirement accounts after leaving a job. Summary When you leave a job, what happens to the retirement account you left behind? In this episode, YFP Co-Founder & CEO, Tim Ulbrich, PharmD, and YFP Co-Founder & COO, Tim Baker, CFP®, RLP®, RICP®, take a deep dive into the important financial decisions surrounding old employer-sponsored retirement plans, such as 401(k)s and 403(b)s. Tim and Tim discuss the impact these often-overlooked accounts can have on your overall financial plan and explore your available options, whether that's leaving the money in your former employer's plan, rolling it over to your new employer's plan, or transferring it to an IRA. They break down the pros and cons of each approach, highlight common mistakes like the “set it and forget it” trap, and explain why understanding fees and account access is so important. The conversation also emphasizes the value of working with a fiduciary advisor and the serious risks of cashing out these accounts too soon. To complement the episode, they introduce YFP's new guide: The Best and Worst Moves to Make with an Old 401(k), designed to help you avoid costly missteps and feel confident in your next move. Whether you're changing jobs, planning ahead for a career transition, or simply want to be more intentional about your retirement savings, this episode will give you the clarity and guidance you need. Mentioned on the Show First Horizon's Pharmacist Home Loan Your Financial Pharmacist YFP Guide: Best & Worst Moves to Make With an Old 401(k) FIRE Rx: The Pharmacist's Guide to Financial Independence YFP Episode 404: 5 Key Questions to Ask Before Hiring a Financial Planner Reference: 2024 Kitces Report on Financial Planning
Join me in today's episode as I sit down and speak with Isabella Wentz as we dive deep into the world of thyroid health, specifically Hashimoto's, and the often-overlooked role of adrenal health. We talk about practical, evidence-based ways to support your body's natural healing processes—things like nourishing your gut, balancing hormones, and making lifestyle changes that truly work. If you're tired of quick fixes and want to understand how to address these complex issues from a root-cause perspective, this episode is for you. Dr. Wentz is an internationally acclaimed thyroid specialist and licensed pharmacist, who has dedicated her career to addressing the root cause of thyroid dysfunction after being diagnosed with Hashimoto's thyroiditis in 2009. Suggested Resources:Dr. Isabella Wentz | Website | Instagram | PodcastAdrenal Transformation Protocol: A 4-Week Plan to Release Stress Symptoms and Go from Surviving to ThrivingAre Your Adrenals Sabotaging Your HealthAdrenal & Stress TestingA Gluten-Free Diet for HashimotosIntestinal permeability – a new target for disease prevention and therapySend me a text!Laconiko's ZOE High Polyphenol Extra Virgin Olive Oil is among the healthiest olive oils due to its remarkably high polyphenol and oleocanthal content. Visit Laconiko.com to learn more or try it out today, and use promo code WellnStrong10 for 10% off your order. Toups & Co offers non-toxic skincare and makeup products that truly make a difference. Their ingredients are pure, organic, and ethically sourced, which means your skin gets nothing but the best. So, if you're ready to treat your skin to the best, head over to Toups & Co and use the code “wellnstrong” for 10% off your order. Trust me, your skin will thank you!Join the WellnStrong mailing list for exclusive content here!Want more of The How To Be WellnStrong Podcast? Subscribe to the YouTube channel. Follow Jacqueline: Instagram Pinterest TikTok Youtube To access notes from the show & full transcripts, head over to WellnStrong's Podcast Page
© 2020-2025 Ivy Podcast Discovery LLC
